Quanterix Eyes Cash-Flow Breakeven in 2026 After Akoya Acquisition and Management Overhaul

On July 8 2025, Quanterix Corporation (NASDAQ: QTRX) announced the completion of its purchase of Akoya Biosciences, a mo...

Read story →